On August 31, 2022, the FDA approved Moderna and Pfizer Bivalent COVID boosters to replace the previously available monovalent boosters. Since then, the CDC and other public health organizations have...
As the COVID-19 pandemic continues and vaccinations continue to be advanced, many patients are concerned about vaccine side effects. Multiple sources have perpetuated the misconception that COVID-19...
In a recent article published in Nature Medicine, researchers shared information on new biomarkers to develop HIV prevention tools. This publication highlighted research from the Antibody Mediated Prevention (AMP) trials. It is thought...
As new COVID boosters are approved and distributed, understanding how they affect pregnant and lactating individuals will impact public health policies, educational efforts, and provider distribution....
The Advanced Research Projects Agency for Health (ARPA-H) was proposed by the Biden Administration on March 15, 2022, as a government organization to drive biomedical and healthcare innovation. Under...
As the COVID pandemic progresses and infection rates fluctuate, public health officials and organizations seek to provide more options to protect against illness. On August 19, Novavax announced that...
The Biden Administration is preparing for a potential coronavirus surge this fall by purchasing millions of variant-specific COVID-19 booster shots. In addition to the 105 million doses already...
Monkeypox was declared a public health emergency by the WHO on Saturday, July 23, 2022. Since the rise of monkeypox rates, public health organizations have urged at-risk populations to seek...
While the general public may feel we are post-pandemic, healthcare workers know that COVID still runs rampant worldwide, especially in hospital settings. The recent study published in JAMA Network Open...
A cohort study in JAMA Network Open analyzed the efficacy of the COVID-19 vaccine in preventing SARS-CoV-2 reinfection. The study found that COVID-19 vaccination reduced reinfection rates by...
A post by the Commonwealth Fund approximates that over 100,000 lives would be saved with fall COVID booster campaigns. Though many people and institutions have the misconceived notion that the COVID...
On Saturday, July 23, 2022, the director-general of the WHO declared monkeypox a public health crisis. Public health organizations have encouraged vaccination for at-risk populations to minimize the...
The Kaiser Family Foundation (KFF) recently found that pediatric COVID-19 vaccination rates in children under 5 years old have decreased despite the age bracket’s very recent eligibility....
In a recent statement, the WHO analyzed global vaccination coverage and found that in 2021 immunization rates dropped by 5%. Furthermore, the WHO outlined the 2030 immunization agenda and international...
On July 13, 2022, the FDA issued an Emergency Use Authorization (EUA) for the Novavax COVID vaccine. Following this approval, the CDC added the Novavax COVID vaccine to their recommended vaccines for...
The HPV vaccine rates have increased in adolescents. Between 2015 and 2020, the rate of HPV vaccination in juveniles expanded by 19.3%. This study looked at data from the National Immunization Surveys...
On June 15, the FDA advisory board unilaterally voted to approve Pfizer’s COVID vaccine for children under 5. Until now, there has been a gap in COVID-related care for children under 5 as...
Earlier this month, the FDA approved GSK’s Priorix measles, mumps, and rubella (MMR) vaccine in the United States for individuals 12 months and older.
MMR vaccines are recommended in a...
The FDA Vaccine and Related Biological Products Advisory Committee (VRBPAC) voted 21 to 0 in favor of recommending the Novavax coronavirus vaccine for emergency...
Data from a study published in February's CDC Morbidity and Mortality Weekly Report suggest that COVID-19 vaccination during pregnancy provides substantial protection for mother and baby.
This...
